Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Neutrophil gelatinase-associated lipocalin (NGAL) is a protein expressed by kidney tubular cells in response to ischemia, but may also be an early indicator of immunological rejection, calcineurin inhibitor toxicity, obstructive nephropathy, subclinical tubulitis or infection. Although there is currently no evidence to support the routine serial measurement of blood or urinary NGAL to detect subclinical acute tubular injury, NGAL has the potential to provide useful information to those that care for kidney transplant recipients (KTRs). First, high urinary or serum NGAL concentrations shortly after transplantation are a predictor of delayed graft function and are associated with reduced graft function at one year. Secondly, among KTRs with previously stable graft function who then suffer acute graft dysfunction, a high urinary NGAL predicts graft loss at one year. If further refined, diagnostic tests based on NGAL levels may provide future useful clinical tools.

Original publication

DOI

10.1016/j.trre.2015.04.004

Type

Journal article

Journal

Transplant Rev (Orlando)

Publication Date

07/2015

Volume

29

Pages

139 - 144

Keywords

Acute-Phase Proteins, Biomarkers, Delayed Graft Function, Graft Rejection, Humans, Kidney Transplantation, Lipocalin-2, Lipocalins, Monitoring, Physiologic, Predictive Value of Tests, Proto-Oncogene Proteins, Time Factors, Transplantation, Homologous